Search Results - "Thienemann, F."

Changes in access to viral load testing, incidence rates of viral load suppression and rebound following the introduction of the 'universal test and treat' guidelines in Cameroon: A retrospective follow-up analysis by Bekolo, C E, Ndeso, S A, Moifo, L L, Mangala, N, Ateudjieu, J, Kouanfack, C, Dzudie, A, Thienemann, F, Tendongfor, N, Nsagha, D S, Choukem, S P

“…Cameroon adopted and started implementing in 2016, the 'universal test and treat' (UTT) guidelines to fast-track progress towards the 95-95-95 ambitious…”
Get full text

WHF position statement on COVID vaccination by Thienemann, F., Chakafana, G., Piñeiro, D., Pinto, Fausto J., Perel, P., Singh, K., Eiselé, J.-L., Prabhakaran, D., Sliwa, K.

“…Copyright: © 2021 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License…”
Get full text

Gender disparities in pulmonary hypertension at a tertiary centre in Cameroon by Kamdem, F., Mapoh, S., Aminde, L.N., Sliwa, K., Kuelang, X., Thienemann, F., Ndjebet, J., Doualla, M-S., Ngu, K.B., Dzudie, A., Mbatchou Ngahane, B.H., Kengne, A.P.

“…Background. Pulmonary hypertension (PH) is a potent cause of heart failure and has been little investigated in the African setting. Objective. To investigate…”
Get full text

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis by Tait, Dereck R, Hatherill, Mark, Van Der Meeren, Olivier, Ginsberg, Ann M, Van Brakel, Elana, Salaun, Bruno, Scriba, Thomas J, Akite, Elaine J, Ayles, Helen M, Bollaerts, Anne, Demoitié, Marie-Ange, Diacon, Andreas, Evans, Thomas G, Gillard, Paul, Hellström, Elizabeth, Innes, James C, Lempicki, Maria, Malahleha, Mookho, Martinson, Neil, Mesia Vela, Doris, Muyoyeta, Monde, Nduba, Videlis, Pascal, Thierry G, Tameris, Michele, Thienemann, Friedrich, Wilkinson, Robert J, Roman, François

“…Mycobacterium tuberculosis remains a major global health threat. In this report, the M72/AS01 E vaccine provided approximately 50% protection against…”
Get full text

Perspectives from the 2nd International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes by Allwood, B.W., Nightingale, R., Agbota, G., Auld, S., Bisson, G.P., Byrne, A., Dunn, R., Evans, D., Hoddinott, G., Günther, G., Islam, Z., Johnston, J.C., Kalyatanda, G., Khosa, C., Marais, S., Makanda, G., Mashedi, O.M., Meghji, J., Mitnick, C., Mulder, C., Nkereuwem, E., Nkereuwem, O., Ozoh, O.B., Rachow, A., Romanowski, K., Seddon, J.A., Schoeman, I., Thienemann, F., Walker, N.F., Wademan, D.T., Wallis, R., van der Zalm, M.M.

“…In 2020, it was estimated that there were 155 million survivors of TB alive, all at risk of possible post TB disability. The 2nd International…”
Get full text

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis by Van Der Meeren, Olivier, Hatherill, Mark, Nduba, Videlis, Wilkinson, Robert J, Muyoyeta, Monde, Van Brakel, Elana, Ayles, Helen M, Henostroza, German, Thienemann, Friedrich, Scriba, Thomas J, Diacon, Andreas, Blatner, Gretta L, Demoitié, Marie-Ange, Tameris, Michele, Malahleha, Mookho, Innes, James C, Hellström, Elizabeth, Martinson, Neil, Singh, Tina, Akite, Elaine J, Khatoon Azam, Aisha, Bollaerts, Anne, Ginsberg, Ann M, Evans, Thomas G, Gillard, Paul, Tait, Dereck R

“…Mycobacterium tuberculosis is a major global pathogen. In this trial in sub-Saharan Africa, a new vaccine was found to have 54% efficacy against the…”
Get full text

HIV and the heart: the impact of antiretroviral therapy: a global perspective by Thienemann, Friedrich, Sliwa, Karen, Rockstroh, Jürgen Kurt

“…From a global perspective, cardiovascular disease (CVD) in human immunodeficiency virus (HIV) may result from cardiac involvement upon presentation of…”
Get full text

Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS by Meintjes, Graeme, Stek, Cari, Blumenthal, Lisette, Thienemann, Friedrich, Schutz, Charlotte, Buyze, Jozefien, Ravinetto, Raffaella, van Loen, Harry, Nair, Amy, Jackson, Amanda, Colebunders, Robert, Maartens, Gary, Wilkinson, Robert J, Lynen, Lutgarde

“…Early initiation of antiretroviral therapy is an important aspect in the care of patients with HIV. In a randomized trial, a low prophylactic dose of…”
Get full text

Evaluation of clinical, laboratory, radiographical and histopathological characteristics in patients with spinal tuberculosis in the context of HIV infection: An analysis of 52 patients from a South African tertiary hospital by Scherer, J, Locketz, M, Castelein, S, Dunn, R, Held, M, Thienemann, F

“…\r\nBackground\r\nSouth Africa (SA) has the highest prevalence of people with tuberculosis (TB) and HIV coinfection globally. People living with HIV have an…”
Get full text

Comparing cardiac MRI and lung PET/CT after completion of tuberculosis treatment – preliminary findings of participants co-enrolled into the StatinTB trial and Cardiac Imaging After TB (CIA-TB) study by Mukasa, S, Aremu, O, Wolmarans, K, Mashinyira, A, Katoto, P, Jakoet-Bassier, F, Kotze, T, Samuels, P, Jaftha, M, Maishi, P, Guler, R, Ntusi, N, Thienemann, F

“…Abstract Introduction Mortality rates after successful tuberculosis (TB) treatment remain elevated and healthy survival is impaired by chronic pulmonary…”
Get full text

Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort by SLIWA, Karen, CARRINGTON, Melinda J, BECKER, Anthony, THIENEMANN, Friedrich, NTSEKHE, Mpiko, STEWART, Simon

“…The contemporary impact of the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) epidemic on heart disease in South Africa (>5…”
Get full text

Preventing intrahospital transmission of COVID-19 : experience from the University Hospital Zurich in Switzerland by Thienemann, Friedrich, Rampini, Silvana K., Sax, Hugo, Wolfensberger, Aline

“…To the Editor: The COVID-19 pandemic that started in China in December 2019 has been declared a public health emergency of international concern by the World…”
Get full text

Changes in access to viral load testing, incidence rates of viral load suppression and rebound following the introduction of the 'universal test and treat' guidelines in Cameroon: A retrospective follow-up analysis by C E Bekolo, S A Ndeso, L L Moifo, N Mangala, J Ateudjieu, C Kouanfack, A Dzudie, F Thienemann, N Tendongfor, D S Nsagha, S P Choukem

“…Cameroon adopted and started implementing in 2016, the 'universal test and treat' (UTT) guidelines to fast-track progress towards the 95-95-95 ambitious…”
Get full text

Central nervous system disorders after starting antiretroviral therapy in South Africa by ASSELMAN, Valerie, THIENEMANN, Friedrich, PEPPER, Dominique J, BOULLE, Andrew, WILKINSON, Robert J, MEINTJES, Graeme, MARAIS, Suzaan

“…To describe the spectrum of central nervous system (CNS) disease during the first year of antiretroviral therapy (ART) and to determine the contribution of…”
Get full text

Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells by THIENEMANN, Friedrich, HENZ, Beate M, BABINA, Magda

“…Mast cells (MC) are of hematopoietic origin but complete their differentiation exclusively within tissues. The mediators that positively or negatively affect…”
Get full text